Clinical Trials Directory

Trials / Unknown

UnknownNCT05502354

CRP-guided Transanal Drainage Removal After Rectal Surgery

A Single Arm Study to Investigate the Safety and Efficacy of C Reactive Protein (CRP) Guided Transanal Drainage Tube (TDT) Removal for Anastomotic Leak (AL) Prevention Following Laparoscopic Anterior Resection for Rectal Carcinoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Transanal drainage tube (TDT) has the benefit of reducing intraluminal pressure after rectal surgery and may provide ideal regional environment for anastomotic healing. Postoperative C-reactive protein (CRP) trajectory has a high negative predictive value of 0.99 for ruling out anastomotic leak (AL). Previously, TDT was removed at the surgeon's own discretion. In the present study, we design a single arm study to investigate the safety and efficacy of CRP-guided TDT removal for AL prevention following laparoscopic anterior resection for rectal carcinoma

Conditions

Interventions

TypeNameDescription
DEVICEremoval of transanal drainage tuberemoval of transanal drainage tube after laparoscopic anterior resection for rectal carcinoma according to postoperative CRP trajectory

Timeline

Start date
2023-04-01
Primary completion
2024-12-31
Completion
2025-02-01
First posted
2022-08-16
Last updated
2023-11-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05502354. Inclusion in this directory is not an endorsement.